The Clorox Company (CLX - Free Report) reported first-quarter fiscal 2018 results, wherein adjusted earnings from continuing operations of $1.46 per share rose 7% year over year and also beat the Zacks Consensus Estimate of $1.41.
The company cut down its earnings guidance for fiscal 2018 in the range of $5.47-$5.67, compared with $5.52–$5.72 per share guided earlier. The current outlook includes an anticipated impact of 10 cents related to hurricanes.
Earnings Estimate Revision: The Zacks Consensus Estimate for the current fiscal has been trending down in the last 30 days. If we look at Clorox’s performance in the trailing four quarters (excluding the quarter under review), the company has outperformed the Zacks Consensus Estimate by an average of 0.4%.
Revenues: Clorox generated net sales of $1,500 million that climbed 4% year over year, beating the Zacks Consensus Estimate of $1,478 million. The year over year increase was backed by volume growth of 4%, along with growth across all the segments.
The company now anticipates sales growth of 1-3% for fiscal 2018 versus increase of 2-4%, expected earlier. The guidance includes a slight reduction of less than 1 point from the divestiture of its Aplicare business.
Zacks Rank: Currently, Clorox carries a Zacks Rank #4 (Sell), which is subject to change following the earnings announcement. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Check back later for our full write up on Clorox’s earnings report!
More Stock News: This Is Bigger than the iPhone!
It could become the mother of all technological revolutions. Apple sold a mere 1 billion iPhones in 10 years but a new breakthrough is expected to generate more than 27 billion devices in just 3 years, creating a $1.7 trillion market.
Zacks has just released a Special Report that spotlights this fast-emerging phenomenon and 6 tickers for taking advantage of it. If you don't buy now, you may kick yourself in 2020.
Click here for the 6 trades >>
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
The Clorox Company (CLX - Free Report) reported first-quarter fiscal 2018 results, wherein adjusted earnings from continuing operations of $1.46 per share rose 7% year over year and also beat the Zacks Consensus Estimate of $1.41.
The company cut down its earnings guidance for fiscal 2018 in the range of $5.47-$5.67, compared with $5.52–$5.72 per share guided earlier. The current outlook includes an anticipated impact of 10 cents related to hurricanes.
Earnings Estimate Revision: The Zacks Consensus Estimate for the current fiscal has been trending down in the last 30 days. If we look at Clorox’s performance in the trailing four quarters (excluding the quarter under review), the company has outperformed the Zacks Consensus Estimate by an average of 0.4%.
Revenues: Clorox generated net sales of $1,500 million that climbed 4% year over year, beating the Zacks Consensus Estimate of $1,478 million. The year over year increase was backed by volume growth of 4%, along with growth across all the segments.
The company now anticipates sales growth of 1-3% for fiscal 2018 versus increase of 2-4%, expected earlier. The guidance includes a slight reduction of less than 1 point from the divestiture of its Aplicare business.
Zacks Rank: Currently, Clorox carries a Zacks Rank #4 (Sell), which is subject to change following the earnings announcement. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Check back later for our full write up on Clorox’s earnings report!
More Stock News: This Is Bigger than the iPhone!
It could become the mother of all technological revolutions. Apple sold a mere 1 billion iPhones in 10 years but a new breakthrough is expected to generate more than 27 billion devices in just 3 years, creating a $1.7 trillion market.
Zacks has just released a Special Report that spotlights this fast-emerging phenomenon and 6 tickers for taking advantage of it. If you don't buy now, you may kick yourself in 2020.
Click here for the 6 trades >>
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Get the latest research report on CLX - FREE